Medicinal cannabis products that meet the minimum quality standard

3 December 2021:  New medicinal cannabis products have been verified as meeting the minimum quality standard  – Read more.

Generally, medicinal cannabis products are only available, on prescription, if they have:

  • been assessed by the Medicinal Cannabis Agency as meeting the minimum quality standard under the Misuse of Drugs (Medicinal Cannabis) Regulations 2019, or
  • obtained consent for distribution under the Medicines Act 1981 (approved and provisionally approved medicines)

Any doctor can prescribe a product listed here. A specialist recommendation and Ministerial approval are not required. For more information on a particular product, please contact the listed product supplier or manufacturer.

Medicinal cannabis products that meet the minimum quality standard under the Misuse of Drugs (Medicinal Cannabis) Regulations 2019

Products that are listed as having been verified as meeting the minimum quality standards are unapproved medicines – there has been no assessment of their safety or efficacy. Being listed here does not guarantee that these products are currently available in New Zealand.

Date Verified Product Classification Dose Form Active Ingredient Pack Sizes Administration Licence Holder
2 Dec 2021 ANTG Eve Controlled Drug C1 Dried product – for preparation as a tea for oral consumption only

Note: This product does not meet the minimum quality standard for product intended for use by inhalation.
Total THC (THC+THCA): 10mg/g (˂ 1% w/w)

Total CBD (CBD+CBDA): 125mg/g (12.5% w/w)
10 g Tea Preparation for oral consumption
  1. Bring 500 ml (0.5 litres) of water to the boil in a covered vessel
  2. Granulate product (using a grinder is easiest) into fine pieces
  3. Add 0.5 gram of product to vessel
  4. Turn down the heat and simmer the tea for 15 minutes with the lid on the vessel
  5. Remove the covered vessel from the heat and strain the tea
  6. Store the leftover tea in a thermos if you are to drink more of it on the same day
After preparation - as described above - add a sachet of coffee creamer powder to the warm tea. This prevents the active ingredients in the tea from sticking to the inside of the teapot or mug after cooling.
MW Pharma Limited t/a NUBU Pharmaceuticals
4 Oct 2021 SubDrops™ CBD100 Prescription Medicine Sublingual Solution Total CBD (CBD+CBDA) 100 mg/mL

Total THC (THC+THCA) ˂1 mg/mL
30 mL Sublingual, supplied with a 1 mL dropper with 0.25 mL volume markings Helius Therapeutics Limited
4 Oct 2021 SubDrops™ CBD25 Prescription Medicine Sublingual Solution Total CBD (CBD+CBDA) 25 mg/mL

Total THC (THC+THCA) ˂1 mg/mL
30 mL Sublingual, supplied with a 1 mL dropper with 0.25 mL volume markings Helius Therapeutics Limited
12 Apr 2021 Tilray FS Oral Solution THC 25 Controlled Drug B1 Solution, Oral Total THC (THC+THCA) 26.6 mg / g (25 mg/ mL)

Total CBD (CBD+CBDA) < 0.5 mg/g
40 mL Oral, 1 mL dropper with volume markings CDC Pharmaceuticals Ltd
19 Mar 2021 Tilray FS Oral Solution THC 10: CBD 10 Controlled Drug B1 Solution, Oral Total THC (THC+THCA) 10.6 mg/g

Total CBD  (CBD+CBDA) 10.6 mg/g
25 mL
40 mL
Oral, 1 mL dropper with volume markings CDC Pharmaceuticals Ltd
5 Mar 2021 Tilray P Oral Solution CBD 100 Prescription Medicine Solution, Oral Total CBD (CBD+CBDA) 106.4 mg/g (100 mg/mL)

Total THC (THC+THCA) ˂0.1 mg/g
25 mL
40 mL
Oral, 1 mL dropper with volume markings CDC Pharmaceuticals Ltd
5 Mar 2021 Tilray P Oral Solution CBD 25 Prescription Medicine Solution, Oral Total CBD (CBD+CBDA) 26.6 mg/g (25 mg/mL)

Total THC (THC+THCA) ˂0.1 mg/g
40 mL Oral, 1 mL dropper with volume markings CDC Pharmaceuticals Ltd

Products with consent for distribution (approved and provisionally approved) under the Medicines Act 1981

Approved and provisionally approved medicines have been assessed by Medsafe and have demonstrated that they meet New Zealand and internationally recognised standards for quality, safety and efficacy. Approved and provisionally approved medicines are not required to be assessed against the minimum quality standard.

Sativex Oral spray
Active ingredient(s) Cannabidiol 25 mg/mL equivalent to Cannabis sativa extract 35 mg–42 mg
Tetrahydrocannabinol 27 mg/mL equivalent to Cannabis sativa extract 38 mg–44 mg
Dose form Oromucosal spray
Sponsor Emerge Health New Zealand Limited
58 Richard Pearse Drive
Airport Oaks, Mangere 2022
Prescribing information Sativex data sheet
Information for consumers Sativex consumer medicine information
Back to top